experiments. * p < 0.05, ** p < 0.01, indicate significant differences compared with vehicle control.
Sup Fig 3. LPAR expression profiling under LPAR agonist treatment
The mRNA expression levels of LPAR2 and LPAR3 were monitored by the treatments of (a, b) 5 μM and 10 μM of GRI977143, (c, d) 5 μM and 10 μM of DMP and (e, f) 80 nM and 100 nM of 2S-OMPT for 24 hr. The quantitative data are represented as the mean ± SD based on at least three independent experiments. *p < 0.05 indicate significant differences compared with vehicle control. 
